Panmure Gordon reissued their under review rating on shares of Chesnara Plc (LON:CSN) in a research report released on Thursday morning.

A number of other research firms also recently issued reports on CSN. Shore Capital restated a house stock rating on shares of Chesnara Plc in a research note on Wednesday, August 31st. Canaccord Genuity raised their price target on Chesnara Plc from GBX 325 ($4.06) to GBX 370 ($4.62) and gave the stock a buy rating in a research note on Thursday, September 1st.

Chesnara Plc (LON:CSN) opened at 335.75 on Thursday. Chesnara Plc has a 12 month low of GBX 248.25 and a 12 month high of GBX 355.00. The stock’s 50 day moving average price is GBX 320.80 and its 200 day moving average price is GBX 311.67. The company’s market capitalization is GBX 424.40 million.

COPYRIGHT VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this article can be viewed at

About Chesnara Plc

Chesnara plc is a holding company, which is engaged in the management of life and pension books of business in the United Kingdom and Western Europe. The Company’s segments include CA, S&P, Movestic, The Waard Group and Other Group Activities. The CA segment is a part of it’s the United Kingdom life insurance and pensions run-off portfolio and consists of the business of Countrywide Assured plc.

Receive News & Stock Ratings for Chesnara Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara Plc and related stocks with our FREE daily email newsletter.